Zachary Cefaratti

Zachary Cefaratti is a Dubai-based investor associated with Dalma Capital, writing $250K-plus checks at pre-seed through Series A into AI/ML in healthcare and health IT software. The Dalma Capital affiliation signals access to a structured investment platform with regional family-office and institutional relationships, and the check size suggests he can lead or co-lead small early rounds rather than acting as a passive signal angel. The explicit AI focus is differentiating in the MENA context, where digital health investors more commonly back consumer telehealth and clinic software than algorithmic clinical tools, and it points to interest in clinical AI, payer automation, and AI-native health IT plays. Founders most likely to fit are AI-driven healthcare software companies with a defensible model and data story, ideally with a path into MENA expansion or Gulf government and payer relationships that Dalma’s platform can unlock. Pure biotech, devices, and consumer wellness are weaker matches. Geographically, MENA-focused and globally ambitious AI healthcare teams will see the strongest network value, while strictly US-domestic teams should evaluate whether a MENA cap-table presence is genuinely useful at this stage. The entry path is a LinkedIn message or a direct approach via Dalma Capital, warmed if possible by a mutual MENA fintech or healthcare connection. Lead with the AI moat, the regulatory and clinical evidence plan, and the specific reason a Dubai-based investor accelerates the company.